Fast Neutron Beams for Boron Neutron Capture Therapy?

被引：0

作者：

Wolber, Gerd ^{[1
,2
]}

机构：

[1] Deutsches Krebsforschungsztr. (DKFZ), Abt. Med. Physik in der Radiologie, Heidelberg

[2] Dept. of Med. Phys. in Radiol./E 020, Deutsches Krebsforschungsztr. (DKFZ), German Cancer Research Centre, D - 69120 Heidelberg

来源：

Zeitschrift fur Medizinische Physik | 2004年 / 14卷 / 01期

关键词：

BNCT; Fast neutrons; Thermal neutrons;

D O I：

10.1078/0939-3889-00192

中图分类号：

学科分类号：

摘要：

In view of Boron Neutron Capture Enhanced Fast Neutron Therapy (BNCEFNT) of brain tumours, the spatial distributions of thermal flux and fast neutron plus photon dose were measured in a hydrogenous cylinder phantom under conditions varying with respect to neutron energy, field size, and irradiation technique. The behaviour of the ratio thermal fluence per unit total dose leads to the conclusion that an appreciable dose contribution from the BNC reaction can be expected only with low energies and large fields. Beams from small apertures (<6×6 cm2) produce only marginal BNC dose contributions, and might gain therapeutic relevance only in combination with a very effective tumour-seeking Boron-10 carrier.

引用

页码：55 / 63

页数：8

共 48 条

[1]

Barth R.F., Soloway A.H., Boron neutron capture therapy of brain tumors - Current status and future prospects, J. Neuro-Oncol., 33, pp. 3-7, (1997)

[2]

Beckurts K.H., Wirtz K., Neutron Physics, (1964)

[3]

Braun K., Peschke P., Et al., A biological transporter for the delivery of peptide nuclear acids to the nuclear compartment of living cells, J. Mol. Biol., 318, pp. 237-243, (2002)

[4]

Buchholz T.A., Laramore G.E., Stelzer K.J., Risler R., Wootton P., Griffin T.W., Boron neutron capture enhanced fast neutron radiotherapy for malignant gliomas and other tumors, J. Neuro-Oncol., 33, pp. 171-178, (1997)

[5]

Burmeister J., Kota Ch., Maughan R.L., Dosimetry of the Boron Neutron Capture Reaction for BNCT and BNCEFNT, Strahlentherapie und Onkologie, 175, SUPPL. II, pp. 115-118, (1999)

[6]

Busse P.M., Harling O.K., Palmer M.R., Kiger III W.S., Kaplan J., Kaplan I., Chuang C.F., Gorley J.T., Riley K.J., Newton T.H., Santa Cruz G.A., Lu X.-Q., Zamenhof R.G., A Critical Examination of the Results from the Harvard-MIT NCT Program Phase I Clinical Trial of NCT for Intracranial Disease, Int. Congress on Neutron Capture Therapy, pp. 1123-1127, (2002)

[7]

Caswell R.S., Coyne J.J., Randolph M.L., Kerma Factors of Elements and Compounds for Neutron Energies below 30 MeV, Int. J. Appl. Radiat. Isot., 33, pp. 1227-1262, (1982)

[8]

Coderre J.A., Morris G.M., The Radiation Biology of Boron Neutron Capture Therapy, Radiation Research, 151, pp. 1-18, (1999)

[9]

Coughlin C., Scott C., Langer C., Coia L., Curran W., Rubin P., Phase II, Two-Arm RTOG Trial (94-11) of Bischloroethyl-Nitrosourea plus Accelerated Hyperfractionated Radiotherapy in Treatment of Newly-Diagnosed Radiosurgery-Ineligible Glioblastoma Multiforme Patients, Int. J. Radiation Oncology Biol. Phys., 48, pp. 1351-1358, (2000)

[10]

Dorn III R.V., Boron Neutron Capture Therapy (BNCT): A Radiation Oncology Perspective, Int. J. Radiation Oncology Biol. Phys., 28, pp. 1189-1201, (1994)

← 1 2 3 4 5 →